Press releases
DexTech Medical announces new positive results from the myeloma study
15 April, 2024The Phase 1 study investigates the efficacy of OsteoDex in patients with progressive multiple myeloma (MM). Progressive disease means that the disease progresses and does not respond to existing treatment. […]
Half-year report July 1 – December 31, 2023
15 February, 2024Summary of the second quarter (2023-10-01 – 2023-12-31) Net sales amounted to MSEK 0,0 (0,0) Operating profit/loss amounted to MSEK -1,4 (-1,2) Earnings per share* SEK -0,06 (-0.06) * Before […]
DexTech Medical announces positive results from the myeloma study
23 January, 2024The first test results from patient 1 have been received and show a very strong effect on the marker of osteoclast activity (CTX). The baseline value for CTX decreases by […]
DexTech Medical informs about the myeloma study, the first patient is treated
13 December, 2023The Phase 1 study investigates the efficacy of OsteoDex in patients with progressive multiple myeloma (MM). The first patient is treated during week 50 at Karolinska University Hospital in Huddinge. […]
Bulletin from the Annual General Meeting
31 October, 2023Today, October 31, 2023, the Annual General Meeting of DexTech Medical AB was held. All resolutions were passed with the required majority. Resolution on adoption of the income statement and […]
Interim report July 1- September 30, 2023
27 October, 2023Summary of the first quarter (2023-07-01 – 2023-09-30) Net sales amounted to MSEK 0,0 (0,0) Operating profit/loss amounted to MSEK -1,1 (-0,8) Earnings per share* SEK -0.05 (-0.04) Cash and […]
DexTech Medical files a new patent application with the European Patent Office
13 October, 2023Dextech has filed a new patent application regarding GMP production (Good Manufacturing Practice) of the company’s lead candidate OsteoDex with the European Patent Office (EPO.Org). The application describes a GMP […]
Dextech Medical AB (publ) Notice to AGM 2023
29 September, 2023WELCOME TO THE ANNUAL GENERAL MEETING 2023 DEXTECH MEDICAL AB (publ) Dextech Medical AB’s shareholders are welcome to attend the Annual General Meeting Tuesday 31 October 2023 at 10.00 in […]
Dextech Medical AB Annual report 220701-230630
20 September, 2023Download the annual report below. DexTech Medical AB Ånnual report 220701-230630
Year-end report July 1, 2021 – June 30, 2022
30 August, 2023By “Company” or “DexTech” is meant DexTech Medical AB with organization number 556664-6203. Summary of the fourth quarter (2022-04-01 – 2022-06-30) Net sales amounted to MSEK 0,0 (0,0) Operating profit/loss […]